(Q33797179)

29 July 2017

1 reference

title

Epstein-barr virus transformation: involvement of latent membrane protein 1-mediated activation of NF-kappaB. (English)

1 reference

29 July 2017

0 references

0 references

1 reference

E D Cahir McFarland

1

1 reference

29 July 2017

K M Izumi

series ordinal

2

1 reference

29 July 2017

G Mosialos

series ordinal

3

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

29 July 2017

1 reference

29 July 2017

18

1 reference

29 July 2017

6959-6964

1 reference

29 July 2017

49

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1203217

29 July 2017

0 references

cites work

Relationship between IkappaBalpha constitutive expression, TNFalpha synthesis, and apoptosis in EBV-infected lymphoblastoid cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

EBV persistence in memory B cells in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

Long-Term Human B Cell Lines Dependent on Interleukin-4 and antibody to CD40

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

Control of apoptosis by Rel/NF-kappaB transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

Virus in cultured lymphoblasts from a New Guinea Burkitt lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

Epstein-Barr virus latent membrane protein-1 (LMP1) C-terminus activation region 2 (CTAR2) maps to the far C-terminus and requires oligomerisation for NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

Detection of Epstein-Barr virus genomes in AIDS related lymphomas: sensitivity and specificity of in situ hybridisation compared with Southern blotting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

Herpes-Type Virus and Chromosome Marker in Normal Leukocytes after Growth with Irradiated Burkitt Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

A membrane protein encoded by Epstein-Barr virus in latent growth-transforming infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

A third viral nuclear protein in lymphoblasts immortalized by Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

Simple Repeat Array in Epstein-Barr Virus DNA Encodes Part of the Epstein-Barr Nuclear Antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

A second nuclear protein is encoded by Epstein-Barr virus in latent infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

Definitive identification of a member of the Epstein-Barr virus nuclear protein 3 family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

Signal transduction pathway of interleukin-4 and interleukin-13 in human B cells derived from X-linked severe combined immunodeficiency patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

The Epstein-Barr virus oncoprotein latent membrane protein 1 engages the tumor necrosis factor receptor-associated proteins TRADD and receptor-interacting protein (RIP) but does not induce apoptosis or require RIP for NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

Expression of Epstein-Barr virus latent membrane protein 1 protects Jurkat T cells from apoptosis induced by serum deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

The death domain kinase RIP mediates the TNF-induced NF-kappaB signal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

Early acquisition of cytomegalovirus and Epstein-Barr virus antibody in several isolated Melanesian populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

Epstein-Barr virus in AIDS-related primary central nervous system lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

Epstein-Barr virus and carcinomas: undifferentiated carcinomas but not squamous cell carcinomas of the nasopharynx are regularly associated with the virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

The establishment of lymphoblastoid lines from adult and fetal human lymphoid tissue and its dependence on EBV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

Transformation of foetal human keukocytes in vitro by filtrates of a human leukaemic cell line containing herpes-like virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

Identification of the filtrable leukocyte-transforming factor of qimr-wil cells as herpes-like virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

Absence of infectious Epstein–Barr virus in blood in acute infectious mononucleosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

Long-term T-cell-mediated immunity to Epstein-Barr virus in man. IV. Development of T-cell memory in convalescent infectious mononucleosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

Activation of the B-cell surface receptor CD40 induces A20, a novel zinc finger protein that inhibits apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

Persistent activation of NF-kappaB by the tax transforming protein of HTLV-1: hijacking cellular IkappaB kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

Epstein-Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-kappaB through a pathway that includes the NF-kappaB-inducing kinase and the IkappaB kinases IKKalpha and IKKbeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

Epstein-Barr virus-infected B cells persist in the circulation of acyclovir-treated virus carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

Mechanism of antigen-driven selection in germinal centres

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

Localization of the major NF-kappaB-activating site and the sole TRAF3 binding site of LMP-1 defines two distinct signaling motifs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

7 January 2021

Role of the TRAF binding site and NF-kappaB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

7 January 2021

Simple repeat sequence in Epstein-Barr virus DNA is transcribed in latent and productive infections

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

7 January 2021

The Epstein-Barr virus LMP1 cytoplasmic carboxy terminus is essential for B-lymphocyte transformation; fibroblast cocultivation complements a critical function within the terminal 155 residues.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

7 January 2021

Orientation and patching of the latent infection membrane protein encoded by Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

7 January 2021

A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

7 January 2021

The last seven transmembrane and carboxy-terminal cytoplasmic domains of Epstein-Barr virus latent membrane protein 2 (LMP2) are dispensable for lymphocyte infection and growth transformation in vitro.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

7 January 2021

The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

7 January 2021

All three domains of the Epstein-Barr virus-encoded latent membrane protein LMP-1 are required for transformation of rat-1 fibroblasts.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

7 January 2021

Epstein-Barr virus latent membrane protein (LMP1) is not sufficient to maintain proliferation of B cells but both it and activated CD40 can prolong their survival.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203217

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1203217

1 reference

Dimensions Publication ID

29 July 2017

0 references

1 reference